NM_005688.4:c.*582G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005688.4(ABCC5):​c.*582G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 152,482 control chromosomes in the GnomAD database, including 12,864 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12819 hom., cov: 32)
Exomes 𝑓: 0.43 ( 45 hom. )

Consequence

ABCC5
NM_005688.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.751

Publications

11 publications found
Variant links:
Genes affected
ABCC5 (HGNC:56): (ATP binding cassette subfamily C member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions in the cellular export of its substrate, cyclic nucleotides. This export contributes to the degradation of phosphodiesterases and possibly an elimination pathway for cyclic nucleotides. Studies show that this protein provides resistance to thiopurine anticancer drugs, 6-mercatopurine and thioguanine, and the anti-HIV drug 9-(2-phosphonylmethoxyethyl)adenine. This protein may be involved in resistance to thiopurines in acute lymphoblastic leukemia and antiretroviral nucleoside analogs in HIV-infected patients. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.486 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC5NM_005688.4 linkc.*582G>A 3_prime_UTR_variant Exon 30 of 30 ENST00000334444.11 NP_005679.2 O15440-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC5ENST00000334444.11 linkc.*582G>A 3_prime_UTR_variant Exon 30 of 30 1 NM_005688.4 ENSP00000333926.6 O15440-1
ABCC5ENST00000437205.5 linkn.*3589G>A non_coding_transcript_exon_variant Exon 30 of 30 5 ENSP00000403510.1 F8WCY8
ABCC5ENST00000265586.10 linkc.*582G>A 3_prime_UTR_variant Exon 29 of 29 5 ENSP00000265586.6 O15440-5
ABCC5ENST00000437205.5 linkn.*3589G>A 3_prime_UTR_variant Exon 30 of 30 5 ENSP00000403510.1 F8WCY8

Frequencies

GnomAD3 genomes
AF:
0.388
AC:
59011
AN:
151926
Hom.:
12812
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.182
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.436
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.502
Gnomad SAS
AF:
0.436
Gnomad FIN
AF:
0.400
Gnomad MID
AF:
0.494
Gnomad NFE
AF:
0.484
Gnomad OTH
AF:
0.437
GnomAD4 exome
AF:
0.433
AC:
189
AN:
436
Hom.:
45
Cov.:
0
AF XY:
0.410
AC XY:
109
AN XY:
266
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
1.00
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.434
AC:
171
AN:
394
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.469
AC:
15
AN:
32
Other (OTH)
AF:
0.167
AC:
1
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.388
AC:
59038
AN:
152046
Hom.:
12819
Cov.:
32
AF XY:
0.387
AC XY:
28732
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.182
AC:
7554
AN:
41494
American (AMR)
AF:
0.436
AC:
6661
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1502
AN:
3468
East Asian (EAS)
AF:
0.503
AC:
2594
AN:
5162
South Asian (SAS)
AF:
0.435
AC:
2095
AN:
4814
European-Finnish (FIN)
AF:
0.400
AC:
4226
AN:
10558
Middle Eastern (MID)
AF:
0.490
AC:
143
AN:
292
European-Non Finnish (NFE)
AF:
0.484
AC:
32914
AN:
67956
Other (OTH)
AF:
0.441
AC:
932
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1735
3469
5204
6938
8673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.405
Hom.:
1762
Bravo
AF:
0.382
Asia WGS
AF:
0.471
AC:
1638
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.60
DANN
Benign
0.63
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3749445; hg19: chr3-183638506; COSMIC: COSV55590062; COSMIC: COSV55590062; API